{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:13:42Z","timestamp":1793092422122,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 5T32GM121290"],"award-info":[{"award-number":["T32 5T32GM121290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\u03b2-Hemolytic streptococci are frequently implicated in necrotizing soft-tissue infections (NSTIs). Clindamycin administration may improve outcomes in patients with serious streptococcal infections. However, clindamycin resistance is growing worldwide, and resistance patterns in NSTIs and their impact on outcomes are unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between 2015 and 2018, patients with NSTI at a quaternary referral center were followed up for the outcomes of death, limb loss, and streptococcal toxic shock syndrome. Surgical wound cultures and resistance data were obtained within 48 hours of admission as part of routine care. Risk ratios for the association between these outcomes and the presence of \u03b2-hemolytic streptococci or clindamycin-resistant \u03b2-hemolytic streptococci were calculated using log-binomial regression, controlling for age, transfer status, and injection drug use\u2013related etiology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 445 NSTIs identified, 85% had surgical wound cultures within 48 hours of admission. \u03b2-Hemolytic streptococci grew in 31%, and clindamycin resistance was observed in 31% of cultures. The presence of \u03b2-hemolytic streptococci was associated with greater risk of amputation (risk ratio, 1.80; 95% confidence interval, 1.07\u20133.01), as was the presence of clindamycin resistance among \u03b2-hemolytic streptococci infections (1.86; 1.10\u20133.16).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\u03b2-Hemolytic streptococci are highly prevalent in NSTIs, and in our population clindamycin resistance was more common than previously described. Greater risk of limb loss among patients with \u03b2-hemolytic streptococci\u2014particularly clindamycin-resistant strains\u2014may portend a more locally aggressive disease process or may represent preexisting patient characteristics that predispose to both infection and limb loss. Regardless, these findings may inform antibiotic selection and surgical management to maximize the potential for limb salvage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa976","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T19:09:13Z","timestamp":1594494553000},"page":"e4592-e4598","source":"Crossref","is-referenced-by-count":29,"title":["Outcomes of \u03b2-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-4474","authenticated-orcid":false,"given":"Dara L","family":"Horn","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma A","family":"Roberts","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Shen","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie D","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Divisions of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M","family":"Bulger","sequence":"additional","affiliation":[{"name":"Division of Trauma and Critical Care, Department of Surgery, University of Washington, Harborview Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel S","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Medicine, Divisions of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-4012","authenticated-orcid":false,"given":"Chloe","family":"Bryson-Cahn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Divisions of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce R H","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Trauma and Critical Care, Department of Surgery, University of Washington, Harborview Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2021121022364330600_CIT0001","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/bjd.15615","article-title":"Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12","volume":"177","author":"Audureau","year":"2017","journal-title":"Br J Dermatol"},{"key":"2021121022364330600_CIT0002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.surg.2012.11.026","article-title":"Contemporary trends in necrotizing soft-tissue infections in the United States","volume":"153","author":"Psoinos","year":"2013","journal-title":"Surgery"},{"key":"2021121022364330600_CIT0003","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/sur.2016.049","article-title":"Necrotizing soft tissue infections: a review","volume":"17","author":"Harbrecht","year":"2016","journal-title":"Surg Infect (Larchmt)"},{"key":"2021121022364330600_CIT0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2014.05.006","article-title":"Moving beyond survival as a measure of success: understanding the patient experience of necrotizing soft-tissue infections","volume":"192","author":"Hakkarainen","year":"2014","journal-title":"J Surg Res"},{"key":"2021121022364330600_CIT0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archsurg.140.2.151","article-title":"Predictors of mortality and limb loss in necrotizing soft tissue infections","volume":"140","author":"Anaya","year":"2005","journal-title":"Arch Surg"},{"key":"2021121022364330600_CIT0006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jss.2019.05.006","article-title":"NSTI organisms and regions: a multicenter study from the American Association for the Surgery of Trauma","volume":"243","author":"Louis","year":"2019","journal-title":"J Surg Res"},{"key":"2021121022364330600_CIT0007","article-title":"Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study","author":"Bruun","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0008","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/archinte.158.15.1704","article-title":"Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults","volume":"158","author":"Gardam","year":"1998","journal-title":"Arch Intern Med"},{"key":"2021121022364330600_CIT0009","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2340\/00015555-2015","article-title":"A male with group B streptococcal necrotizing fasciitis at multiple sites secondary to multifocal septic arthritis","volume":"95","author":"Umemura","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"2021121022364330600_CIT0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10096-004-1154-0","article-title":"Group B Streptococcus necrotizing fasciitis: an emerging disease?","volume":"23","author":"Wong","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021121022364330600_CIT0011","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/01443610902883304","article-title":"Group B streptococcal necrotising fasciitis following normal vaginal delivery","volume":"29","author":"Gandhi","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"2021121022364330600_CIT0012","doi-asserted-by":"crossref","first-page":"E545","DOI":"10.1111\/1469-0691.12276","article-title":"Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway","volume":"19","author":"Bruun","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2021121022364330600_CIT0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2334-13-381","article-title":"Fournier\u2019s gangrene of the penis caused by Streptococcus dysgalactiae subspecies equisimilis: case report and incidence study in a tertiary-care hospital","volume":"13","author":"Anantha","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2021121022364330600_CIT0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Executive summary: practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0015","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2021121022364330600_CIT0016","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linn\u00e9r","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0017","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","article-title":"Invasive group A streptococcal infections in Florida","volume":"96","author":"Mulla","year":"2003","journal-title":"South Med J"},{"key":"2021121022364330600_CIT0018","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"2021121022364330600_CIT0020","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/iai.64.12.5395-5398.1996","article-title":"Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G","volume":"64","author":"Norrby-Teglund","year":"1996","journal-title":"Infect Immun"},{"key":"2021121022364330600_CIT0021","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci","volume":"18","author":"Mascini","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"2021121022364330600_CIT0022","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/20.Supplement_2.S154","article-title":"Antibiotic effects on bacterial viability, toxin production, and host response","volume":"20","author":"Stevens","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0023","first-page":"269","article-title":"Clindamycin affects group A Streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"key":"2021121022364330600_CIT0024","doi-asserted-by":"crossref","first-page":"21117","DOI":"10.2807\/1560-7917.ES2015.20.18.21117","article-title":"Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013","volume":"20","author":"Pesola","year":"2015","journal-title":"Euro Surveill"},{"key":"2021121022364330600_CIT0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016","volume":"8","author":"Lu","year":"2017","journal-title":"Front Microbiol"},{"key":"2021121022364330600_CIT0026","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.medmal.2015.10.008","article-title":"Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin","volume":"45","author":"Plainvert","year":"2015","journal-title":"Med Mal Infect"},{"key":"2021121022364330600_CIT0027","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/432473","article-title":"Macrolide-resistant Streptococcus pyogenes in the United States, 2002\u20132003","volume":"41","author":"Richter","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021121022364330600_CIT0028","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000001442","article-title":"Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis","volume":"36","author":"De Muri","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2021121022364330600_CIT0029","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1128\/JCM.42.3.1263-1264.2004","article-title":"Resistance of group B Streptococcus to selected antibiotics, including erythromycin and clindamycin","volume":"42","author":"Heelan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2021121022364330600_CIT0030","doi-asserted-by":"crossref","first-page":"727505","DOI":"10.1155\/2008\/727505","article-title":"Antibiotic resistance patterns in invasive group B streptococcal isolates","volume":"2008","author":"Castor","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2021121022364330600_CIT0031","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1128\/JCM.01262-13","article-title":"Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010","volume":"51","author":"Loubinoux","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021121022364330600_CIT0032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/TA.0000000000001860","article-title":"Validation of the American Association for the Surgery of Trauma emergency general surgery grade for skin and soft tissue infection","volume":"84","author":"Ray-Zack","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"2021121022364330600_CIT0033","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"26th ed. CLSI supplement M100S","author":"CLIS.","year":"2016"},{"key":"2021121022364330600_CIT0034","author":"National Notifiable Diseases Surveillance System, Centers for Disease Control and Prevention."},{"key":"2021121022364330600_CIT0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/sur.2009.012","article-title":"Treatment of complicated skin and soft tissue infections","volume":"10","author":"May","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"2021121022364330600_CIT0036","first-page":"195","article-title":"Necrotizing fasciitis: epidemiology and clinical predictors for amputation","volume":"8","author":"Khamnuan","year":"2015","journal-title":"Int J Gen Med"},{"key":"2021121022364330600_CIT0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/wrr.12370","article-title":"Analysis of the chronic wound microbiota of 2963 patients by 16S rDNA pyrosequencing","volume":"24","author":"Wolcott","year":"2016","journal-title":"Wound Repair Regen"},{"key":"2021121022364330600_CIT0038","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/TA.0000000000002636","article-title":"Predictors of mortality, limb loss, and discharge disposition at admission amongst patients with necrotizing skin and soft tissue infections","volume":"89","author":"Horn","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"2021121022364330600_CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.ARBA-0008-2017","article-title":"Antimicrobial resistance in Streptococcus spp","volume":"6","author":"Haenni","year":"2018","journal-title":"Microbiol Spectr"},{"key":"2021121022364330600_CIT0040","doi-asserted-by":"crossref","first-page":"e0214052","DOI":"10.1371\/journal.pone.0214052","article-title":"Evaluation of blood culture epidemiology and efficiency in a large European teaching hospital","volume":"14","author":"Nannan Panday","year":"2019","journal-title":"PLoS One"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa976\/34137157\/ciaa976.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/11\/e4592\/41607688\/ciaa976.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/11\/e4592\/41607688\/ciaa976.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:38:06Z","timestamp":1639175886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/11\/e4592\/5956896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,5]]},"published-print":{"date-parts":[[2021,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa976","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2020,11,5]]}}}